Renal Diseases Market Reports Empesis on Targeting Immune and Hormone Signaling Dominating the Pipeline for Chronic Kidney Disease

The Frontier Pharma: Renal Diseases High Degree of Innovation and Diversity with Products Targeting Immune and Hormone Signaling Dominating the Pipeline for Chronic Kidney Disease assesses first-in-class innovation in the renal diseases pipeline, highlighting key trends and emerging treatment classes.

Pune, India - March 14, 2018 /MarketersMedia/ —

The renal diseases therapy area encompasses a range of diseases of the kidney, such as chronic kidney disease (CKD), acute kidney injury, diabetic nephropathy and focal segmental glomerulosclerosis. Renal diseases are becoming increasingly common due to the increased prevalence of hypertension and diabetes, two major causes of CKD. For most forms of renal diseases, early detection and management may slow down or prevent progression to renal failure and associated complications. However, many renal diseases are typically asymptomatic until they have progressed to end-stage renal disease (ESRD), which requires renal replacement therapies such as hemodialysis and renal transplantation, and is associated with substantial morbidity and mortality.

Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-renal-diseases-high-degree-of-innovation-and-diversity-with-products-targeting-immune-and-hormone-signaling-dominating-the-pipeline-for-chronic-kidney-disease

The first-in-class programs identified show considerable diversity, and the relatively high degree of innovation in the renal diseases therapy area makes for a promising development pipeline. It is clear that recent activity in this area has increased, partly owing to the growing recognition of the unmet medical need. Further investment in innovation would benefit the therapy area greatly, and likely prove a worthwhile investment, particularly for highly prevalent diseases such as CKD and diabetic nephropathy, for which there are a lack of effective pharmacotherapeutic options.

Get this report at: https://www.themarketreports.com/report/buy-now/935551

Scope
• With 365 products in active development, the pipeline is modestly sized. Does current pipeline innovation hold the potential to affect the future renal diseases market?
• There are 100 first-in-class products in the renal diseases pipeline. Which of these hold the greatest potential to improve future disease treatment with regard to their molecular target?
• The majority of first-in-class products were in development for indications involving inflammation. Which first-in-class targets are most promising, and how does the ratio of first-in-class targets to first-in-class products differ by stage of development and molecular target class?
• A significant number of first-in-class products have been identified with no prior involvement in deals. How do deal frequency and value compare between target families and molecule types, and which first-in-class programs have not yet been involved in a licensing or co-development deal?

Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935551

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/renal-diseases-market-reports-empesis-on-targeting-immune-and-hormone-signaling-dominating-the-pipeline-for-chronic-kidney-disease/314328

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-renal-diseases-high-degree-of-innovation-and-diversity-with-products-targeting-immune-and-hormone-signaling-dominating-the-pipeline-for-chronic-kidney-disease%20%20

Source: MarketersMedia

Release ID: 314328

More Press Releases

Global shares rise as traders shrug off new China-US tariffs

Sep 19, 2018

TOKYO — Global shares were mostly higher Wednesday despite jitters over the escalating trade dispute between the U.S. and China. KEEPING SCORE: France's CAC 40 edged up 0.3 percent to 5,380.16, while Germany's DAX gained 0.2 percent to 12,185.36. Britain's FTSE 100 was flat at 7,301.46. U.S. shares were set to rise with Dow futures up 0.1 percent at 26,325. S&P 500 futures were flat at 2,911.80. ASIA'S DAY: Japan's benchmark Nikkei 225 added 1.1 percent to finish at 23,672.52. Australia's S&P/ASX 200 was up 0.5 percent at 6,190.00. South Korea's Kospi was virtually unchanged at 2,308.46. Hong Kong's Hang...

Asian shares rise as traders shrug off new China-US tariffs

Sep 19, 2018

TOKYO — Asian shares were mostly higher Wednesday, despite jitters over the escalating trade dispute between the U.S. and China. KEEPING SCORE: Japan's benchmark Nikkei 225 added 1.4 percent in early trading to 23,741.29. Australia's S&P/ASX 200 rose 0.4 percent to 6,195.70. South Korea's Kospi slipped 0.3 percent to 2,303.34. Hong Kong's Hang Seng advanced 1.0 percent to 27,355.73, while the Shanghai Composite also jumped 1.0 percent, to 2,726.27. TRADE TENSIONS: The administration of President Donald Trump has decided to impose tariffs on an additional $200 billion of Chinese goods. China responded by saying it will go ahead with plans...

The Latest: China's premier appeals for global support

Sep 19, 2018

NEW YORK — The Latest on the U.S.-China trade war (all times local): ___ 11:30 p.m. China's No. 2 leader has appealed for global support for free trade following tit-for-tat U.S. and Chinese tariff hikes in an escalating battle over Beijing's technology policy. Premier Li Keqiang said Wednesday in a speech to a business conference that disputes must be worked out through consultation. China announced a tariff hike on $60 billion of American imports on Tuesday in response to U.S. President Donald Trump's increase on $200 billion of Chinese goods. Speaking at the World Economic Forum in the eastern city...

Venezuela doubles down on Chinese money to reverse crisis

Sep 19, 2018

CARACAS, Venezuela — Venezuelan President Nicolas Maduro said Tuesday that new investments from China will help his country dramatically boost its oil production, doubling down on financing from the Asian nation to turn around its crashing economy. Already a major economic partner, China has agreed to invest $5 billion more in Venezuela, Maduro said following a recent trip to Beijing, adding that the money would help it nearly double its oil exports to China. "We are taking the first steps into a new economic era," he said. "We are on track to have a new economy, and the agreements with...

Markets Right Now: Markets shrug off trade and end higher

Sep 19, 2018

NEW YORK — The latest on developments in financial markets (all times local): 4 p.m. Investors shrugged off the latest escalation of trade tensions between the U.S. and China and sent stocks broadly higher on Wall Street. Major U.S. indexes on Tuesday gained back nearly all the ground they lost the day before. Technology and consumer-focused companies had some of the biggest gains. Chipmaker Micron Technology rose 4.1 percent and Netflix jumped 5 percent. Ferrari rose 4.2 percent after the sportscar maker announced a new lineup of models. The S&P 500 index rose 15 points, or 0.5 percent, to 2,904....

Subscribe to our newsletter!

Your Name

Your Email Address